IRD vs GILD: Which Stock is Better?
Side-by-side comparison of Opus Genetics Inc and Gilead Sciences Inc in 2026
IRD
Opus Genetics Inc
$5.75
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | IRD | GILD | Winner |
|---|---|---|---|
| Market Cap | $409.11M | $170.84B | GILD |
| P/E Ratio | N/A | 20.27 | GILD |
| EPS (TTM) | $N/A | $6.79 | GILD |
| Revenue Growth | -0.1% | 0.0% | GILD |
| Gross Margin | -117.0% | 78.8% | GILD |
Analyze IRD
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IRD or GILD a better investment?
Comparing IRD and GILD: Opus Genetics Inc has a market cap of $409.11M while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IRD and GILD?
IRD (Opus Genetics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IRD or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IRD or GILD?
GILD has higher revenue growth at 0.0% vs -0.1% for IRD.
Which company is more profitable: IRD or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -117.0% for IRD.
Which is the larger company: IRD or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $409.11M for IRD.
Should I buy IRD or GILD in 2026?
Both IRD and GILD have investment merit. IRD trades at $5.75 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IRD and GILD stock?
Key differences: Market Cap ($409.11M vs $170.84B), P/E Ratio (N/A vs 20.3x), Revenue Growth (-0.1% vs 0.0%), Gross Margin (-117.0% vs 78.8%).